01 / DESIGN
What was studied?
This multicenter, double-blind, placebo-controlled study enrolled 117 adults undergoing bowel resection. The key efficacy measure was the time until a standardized solid meal could be tolerated; adverse events were also monitored.
02 / FINDINGS
What did the researchers report?
The median time to a tolerated meal was numerically shorter with ipamorelin, but the difference was not statistically significant. The investigators found no significant differences in the key or secondary efficacy analyses.
03 / LIMITS
How should it be interpreted?
A numerical difference alone does not establish efficacy. The authors described a small proof-of-concept study with a heterogeneous surgical population. Its hospital setting and study formulation do not support personal-use recommendations or claims about catalog materials.
Loti Labs Peptide editorial reading note. Based on the linked source record. Methods and corrections.